• Explore /
  • Poster
  • / Integrating peripheral biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

Integrating peripheral biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

Abstract Poster

Authors

Toni Choueiri

Toni K. Choueiri

Dana-Farber Cancer Institute, The Lank Center for Genitourinary Oncology, Boston, MA

Toni K. Choueiri , Amber C Donahue , Brian I. Rini , Thomas Powles , John B. A. G. Haanen , James Larkin , Xinmeng Jasmine Mu , Jie Pu , Despina Thomaidou , Alessandra Di Pietro , Paul B. Robbins , Robert J. Motzer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT02684006

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4547)

DOI

10.1200/JCO.2021.39.15_suppl.4547

Abstract #

4547

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: John B. A. G. Haanen

First Author: Yoshihiko Tomita

First Author: Yoshihiko Tomita

First Author: Yoshihiko Tomita